Delivery Order SPE2DB22D3102-SPE2DB24FL1LS

Award Date 6/3/24
Potential Completion Date 6/4/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) is a $2,031.96 firm fixed-price delivery order for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has an ultimate completion date of April 30, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $4,789.62 firm fixed price delivery order from the Defense Logistics Agency (DLA) to supply 4564539408 - TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The award has an ultimate completion date of May 9, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,031.96 firm-fixed-price contract has a completion date of May 7, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order contract valued at $3,789.86. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,953.04 firm fixed-price delivery order is for TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a completion date of May 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA) under a Delivery Order valued at $3,308.04. The contract has a firm fixed price and an ultimate completion date of May 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $2,919.12, was issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $5,788.02 for the supply of 4564954615 - TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of June 21, 2024 and was awarded on June 20, 2024 by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,685.28 firm fixed-price delivery order is for the pharmaceutical product TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of June 5, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was issued by the Defense Logistics Agency (DLA) for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The Firm Fixed Price Delivery Order, valued at $2,468.31, has a period of performance through June 14, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide...
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • SPE2DB22D3102-SPE2DB24FL1LS
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $1,161.12 Firm Fixed Price Delivery Order for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 4, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific contract award does not have a set-aside designation.

Generated 9/2/24, 3:29 PM